16 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... , a half B-profile ... #BLUE #protocol ... #Algorithm #Dyspnea ... #Pulmonary #Ultrasound
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... #PE #Pulmonary # ... Embolism #Treatment ... #hematology #VTE
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... to the ICU The BLUE-protocol ... , a half B-profile ... #protocol #Algorithm ... #Pulmonary #Ultrasound
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... the ICU The BLUE-protocol ... B profile is a half ... , a half B-profile ... dyspnea-criticalcare-pulmonary-algorithm-pocus
Algorithm for the Long-Term Treatment of Venous Thromboembolism 

Reference: https://doi.org/10.1182/blood.2019002364

by Dr. Clive Kearon and Dr. Susan
Algorithm for the ... Long-Term Treatment ... #LongTerm #Treatment ... Anticoagulation #Algorithm ... #Hematology
Nail Disorders secondary to Systemic Diseases
Nail Fold Abnormality
 • SLE
 • Scleroderma
 • Dermatomyositis
Koilonychia - Spoon-shaped
malnutrition) Blue ... Diabetes Mellitus Half-and-Half ... Systemic #Secondary #dermatology ... Differential #Diagnosis #Algorithm
Petechiae/Purpura - Diagnostic Algorithm. Pathophysiology: 1) Represent the passage of erythrocytes from the intravascular to extravascular
Purpura - Diagnostic Algorithm ... Pathophysiology: ... commonly renal and pulmonary ... #Diagnosis #Dermatology ... Purpura #Palpable #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... thrombosis; PE = pulmonary ... Malignancy #Cancer #Algorithm ... Anticoagulation #Management #Hematology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
blood donor • Pathophysiology ... : 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment ... Transfusion #Reactions #hematology
Lymphomas and Lymphoproliferative Disorders - Differential Diagnosis Algorithm
Hodgkin Lymphoma ~40% - Characteristic For Reed-Sternberg (RS) Cells
Differential Diagnosis Algorithm ... Responsive to Treatment ... Classification #pathophysiology ... #Hematology #Diagnosis ... #differential #algorithm